JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 48:262-267, doi:10.1016/j.jacc.2006.01.080 (Published online 22 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elezi, S.
Right arrow Articles by Kastrati, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elezi, S.
Right arrow Articles by Kastrati, A.

Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease

Shpend Elezi, MD*, Alban Dibra, MD*, Ulrike Folkerts, MD*, Julinda Mehilli, MD*, Sylvia Heigl{dagger}, Albert Schömig, MD{dagger} and Adnan Kastrati, MD*,*

* Deutsches Herzzentrum, Technische Universität; Munich, Germany.
{dagger} 1. Medizinische Klinik rechts der Isar, Technische Universität; Munich, Germany.


Figure 1
View larger version (34K):

[in a new window]
  		Figure 1 Initial hospital costs and follow-up costs for the patients who underwent implantation of sirolimus-eluting and paclitaxel-eluting stents. p < 0.001 for the difference between the 2 drug-eluting stents with respect to follow-up costs.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.